ER+ Breast CancerER-Positive / HER2-Negative
Quercetin Notes on ER+ and Aromatase Modulation
Notes on quercetin in ER-positive breast cancer, including dose dependency, COMT activity, and aromatase questions
This page is for notes on quercetin in ER-positive breast cancer.
The key questions here are dose dependency, aromatase modulation, and how COMT activity may affect interpretation.
Why this belongs here
This is not just a compounds page.
It is a receptor-positive endocrine-context page, because the main issue is how quercetin might behave in ER-driven disease.
Current focus
Use this page for:
quercetin in ER-positive settings
aromatase-modulation questions
dose-dependent interpretation
COMT-related caution or nuance